Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_assertion description "[Furthermore, the use of the FDA-approved drug trifluoperazine hydrochloride (TFP), which has been shown to inhibit FOXO1 nuclear export, restored sensitivity to AKT-driven erlotinib resistance through modulation of the KLF6/FOXO1 signaling cascade in both cell culture and xenograft models of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_assertion evidence source_evidence_literature NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_assertion SIO_000772 22653055 NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_assertion wasDerivedFrom befree-20140225 NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_assertion wasGeneratedBy ECO_0000203 NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP296158.RAw1QIZLHX4TkJQrJUofAFf9Zarift_5HIwbXt1WZsk7E130_provenance.